immuno-oncology

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Imugene HER2 vaccine hits target in stomach cancer trial

A peptide vaccine developed by Australia's Imugene has reduced tumour size in around half of patients with HER2-positive gastric or gastroesophageal junction (GEJ) cancer in a phase 2 trial

News

Merck pulls Keytruda's FDA nod for third-line stomach cancer

Merck & Co will voluntarily withdraw a US marketing approval for cancer immunotherapy blockbuster Keytruda in gastric cancer, after studies intended to confirm its efficacy in this sett

Views & Analysis

Deep Dive: Oncology 2021

This has probably been the toughest year for oncology researchers in memory.

News

Libtayo gets a double with EU approvals in skin, lung cancer

Sanofi and Regeneron's checkpoint inhibitor Libtayo has tripled its approved uses in Europe, after getting the nod for the treatment of advanced basal cell carcinoma (BCC) and advanced non-

News

AbbVie jumps on the BCMA train, opting into TeneoOne buy

After dipping its toe into the BCMA water with an option to codevelop a bispecific antibody developed by TeneoOne, AbbVie has gone one step further – agreeing to buy the drug and the compan

News

Arcus preps more phase 3 trials for TIGIT antibody, as Gilea...

Armed with a positive mid-stage trial readout in lung cancer, Arcus Biosciences will expand a phase 3 programme for domvanalimab, its anti-TIGIT antibody.

Imugene HER2 vaccine hits target in stomach cancer trial

Merck pulls Keytruda's FDA nod for third-line stomach cancer

Deep Dive: Oncology 2021

Libtayo gets a double with EU approvals in skin, lung cancer

AbbVie jumps on the BCMA train, opting into TeneoOne buy

Arcus preps more phase 3 trials for TIGIT antibody, as Gilea...

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

immuno-oncology

Editor's Picks